The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - MGP LN

4 Jul 2023 15:30

RNS Number : 9335E
Syquant Capital
04 July 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Medica Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

July 3, 2023

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.2p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Derivatives (other than options):

3,443,079

2.79%

 

(3) Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

3,443,079

2.79%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

0.2p ordinary

 

CFD

 

increasing a long position

 

4,000

 

211 GBp

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

July 4, 2023

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETNKQBNKBKDOOK
Date   Source Headline
23rd Jul 201912:02 pmRNSPrice Monitoring Extension
8th Jul 20194:38 pmRNSChange of Registered Address
7th Jun 201912:02 pmRNSPrice Monitoring Extension
31st May 201912:06 pmRNSNotification of Major Holdings
29th May 201910:13 amRNSNotification of Major Holdings
22nd May 20193:15 pmRNSResult of AGM
22nd May 20197:00 amRNSAnnual General Meeting Statement
9th May 20197:00 amRNSDr Stuart Quin appointed Chief Executive Officer
7th May 20199:33 amRNSNotification of Major Holdings
3rd May 20191:30 pmRNSDirector/PDMR Shareholding
26th Apr 20197:01 amRNSDirector/PDMR Shareholding
26th Apr 20197:01 amRNSDirector/PDMR Shareholding
26th Apr 20197:00 amRNSPosting of Annual Report, Accounts, Notice of AGM
25th Apr 20191:36 pmRNSNotification of Major Holdings
25th Apr 20197:00 amRNSJo Easton Appointed Non-Executive Director
5th Apr 201911:58 amRNSHolding(s) in Company
3rd Apr 20194:40 pmRNSSecond Price Monitoring Extn
3rd Apr 20194:35 pmRNSPrice Monitoring Extension
25th Mar 20197:00 amRNSFinal Preliminary Results
26th Feb 20199:41 amRNSHolding(s) in Company
24th Jan 20197:00 amRNSPost-Close Trading Update
22nd Jan 201911:39 amRNSNotification of Major Holdings
22nd Jan 201911:38 amRNSNotification of Major Holdings
11th Jan 20194:35 pmRNSPrice Monitoring Extension
20th Dec 20187:00 amRNSNon-executive Director Change
4th Dec 20187:02 amRNSPrice Monitoring Extension
3rd Dec 20184:35 pmRNSPrice Monitoring Extension
25th Sep 20189:15 amRNSNotification of Major Holdings
21st Sep 20185:43 pmRNSDirector/PDMR Shareholding
19th Sep 20184:35 pmRNSPrice Monitoring Extension
12th Sep 20187:00 amRNSUnaudited half year results
23rd Aug 20184:35 pmRNSPrice Monitoring Extension
3rd Aug 201811:17 amRNSNotification of Major Holdings
27th Jul 20184:45 pmRNSNotification of Major Holdings
25th Jul 20187:00 amRNSPre-Close Trading Update
12th Jul 20184:13 pmRNSNotification of Major Holdings
3rd Jul 20189:00 amRNSNotice of Interim Results
2nd Jul 20184:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20184:35 pmRNSPrice Monitoring Extension
26th Jun 201812:49 pmRNSNotification of Major Holdings
25th Jun 20183:49 pmRNSNotification of Major Holdings
12th Jun 20184:40 pmRNSSecond Price Monitoring Extn
12th Jun 20184:35 pmRNSPrice Monitoring Extension
23rd May 20184:16 pmRNSResult of AGM
23rd May 20187:00 amRNSAnnual General Meeting Statement
21st May 201810:03 amRNSNotification of Major Holdings
17th May 20189:56 amRNSHolding(s) in Company
16th May 201810:45 amRNSHolding(s) in Company
27th Apr 201811:30 amRNSAmendments to Notice of Annual General Meeting
25th Apr 20184:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.